Metastatic Castration-resistant Prostate Cancer Clinical Trials in Albuquerque, New Mexico

5 studies are recruiting for metastatic castration-resistant prostate cancer in Albuquerque, New Mexico right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

    Hormone therapy, or androgen deprivation therapy (ADT) is a standard way to treat prostate cancer. It works by reducing the amount of the main male sex hormone, testosterone in the body. Androgen receptor pathway inhibitors (ARPIs) are another type of hormone therapy. They either slow down how much…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    New Mexico Oncology Hematology Consultants, Albuquerque, New Mexico
    Locations
    54 in total
    Run by
    Astellas Pharma Global Development, Inc.

    See if you can join NCT07005154 on ClinicalTrials.gov

  2. AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

    The intention of the study is to demonstrate superiority of AZD2265 relative to standard of care treatments by assessment of radiographic progression-free survival (rPFS) and overall survival (OS) in participants with mCRPC.

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Research Site, Albuquerque, New Mexico
    Locations
    132 in total
    Run by
    AstraZeneca

    See if you can join NCT07611110 on ClinicalTrials.gov

  3. A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

    The purpose of this study is to evaluate the safety, efficacy, tolerability, and pharmacokinetics (PK) of FG-3246, a cluster of differentiation 46 (CD46) targeting antibody-drug conjugate (ADC), in the treatment of participants with mCRPC who have progressed following treatment with one prior secon…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    New Mexico Oncology Hematology Consultants, Ltd., Albuquerque, New Mexico
    Locations
    23 in total
    Run by
    Kyntra Bio

    See if you can join NCT06842498 on ClinicalTrials.gov

  4. Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

    TROPION-PanTumor03 will investigate the safety, tolerability, and anti-tumour activity of Datopotamab Deruxtecan (Dato-DXd) as Monotherapy and in Combination with Anticancer Agents in Patients with Advanced/Metastatic Solid Tumours.

    Stage
    Phase 2
    Ages
    18 to 130
    Site
    Research Site, Albuquerque, New Mexico
    Locations
    96 in total
    Run by
    AstraZeneca

    See if you can join NCT05489211 on ClinicalTrials.gov

  5. A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

    Medicines that reduce the amount of testosterone in the body are commonly used to treat prostate cancer. PRL-02 depot is a potential treatment for men with advanced prostate cancer. It is given by an injection into the muscle. Men with advanced prostate cancer can take part in this study. Their can…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    New Mexico Oncology Hematology Consultants Ltd, Albuquerque, New Mexico
    Locations
    25 in total
    Run by
    Astellas Pharma Global Development, Inc.

    See if you can join NCT04729114 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.